- Home
- PEG vs ALC Comparison
PEG vs ALC Comparison
Compare PEG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEG
- ALC
- Stock Information
- Founded
- PEG 1903
- ALC 1945
- Country
- PEG United States
- ALC Switzerland
- Employees
- PEG N/A
- ALC N/A
- Industry
- PEG Power Generation
- ALC Ophthalmic Goods
- Sector
- PEG Utilities
- ALC Health Care
- Exchange
- PEG Nasdaq
- ALC Nasdaq
- Market Cap
- PEG 41.4B
- ALC 44.0B
- IPO Year
- PEG N/A
- ALC N/A
- Fundamental
- Price
- PEG $81.62
- ALC $95.78
- Analyst Decision
- PEG Buy
- ALC Buy
- Analyst Count
- PEG 13
- ALC 12
- Target Price
- PEG $90.55
- ALC $104.90
- AVG Volume (30 Days)
- PEG 3.3M
- ALC 1.4M
- Earning Date
- PEG 04-29-2025
- ALC 05-12-2025
- Dividend Yield
- PEG 3.09%
- ALC 0.28%
- EPS Growth
- PEG N/A
- ALC 4.59
- EPS
- PEG 3.54
- ALC 2.05
- Revenue
- PEG $10,290,000,000.00
- ALC $9,911,000,000.00
- Revenue This Year
- PEG $7.56
- ALC $6.19
- Revenue Next Year
- PEG $5.29
- ALC $7.00
- P/E Ratio
- PEG $23.06
- ALC $46.54
- Revenue Growth
- PEG N/A
- ALC 4.82
- 52 Week Low
- PEG $64.03
- ALC $77.54
- 52 Week High
- PEG $95.22
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- PEG 48.06
- ALC 61.36
- Support Level
- PEG $80.52
- ALC $90.64
- Resistance Level
- PEG $84.56
- ALC $97.40
- Average True Range (ATR)
- PEG 1.55
- ALC 1.31
- MACD
- PEG 0.14
- ALC 0.53
- Stochastic Oscillator
- PEG 55.05
- ALC 84.79
About PEG Public Service Enterprise Group Incorporated
Public Service Enterprise Group is the holding company for a regulated utility (PSE&G) and PSEG Power, which owns all or a share of three nuclear plans and clean energy projects. PSE&G provides regulated gas and electricity delivery services in New Jersey to a combined 4.3 million customers. Public Service Enterprise Group also operates the Long Island Power Authority system. In 2022, the company sold its gas and oil power plants in the mid-Atlantic, New York, and the Northeast.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.